Effects of Lonicera japonica Thunb. on type 2 diabetes via PPAR-γ activation in rats

Phytotherapy Research

Volumn 29, Issue 10, 2015, Pages 1616-1621

  Han, Jae Min ^a   Kim, Mi Hye ^a   Choi, You Yeon ^a   Lee, Haesu ^a   Hong, Jongki ^a   Yang, Woong Mo ^a  

^a Kyung Hee University   (South Korea)

Author keywords

anti diabetic; anti hyperglycemic; Lonicera japonica Thunb; PPAR ; type 2 diabetes mellitus

Indexed keywords

LONICERA JAPONICA EXTRACT; METFORMIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; STREPTOZOCIN; PLANT EXTRACT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDIABETIC ACTIVITY; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVATION; FOOD INTAKE; GLUCOSE BLOOD LEVEL; HERBAL MEDICINE; HISTOPATHOLOGY; HOMEOSTASIS; INSULIN RESISTANCE; LIPID DIET; LONICERA JAPONICA; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; PROTEIN EXPRESSION; RAT; ANIMAL; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; HYPERGLYCEMIA; LONICERA; MEDICINAL PLANT; METABOLISM; PHYTOTHERAPY;

ANIMALS; BODY WEIGHT; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; DIET, HIGH-FAT; HYPERGLYCEMIA; INSULIN RESISTANCE; LONICERA; MALE; PHYTOTHERAPY; PLANT EXTRACTS; PLANTS, MEDICINAL; PPAR GAMMA; RATS; STREPTOZOCIN;

EID: 84943542807     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.5413     Document Type: Article

References (31)

1. Adefegha SA, Oboh G, Adefegha OM, Boligon AA, Athayde ML,. 2014. Antihyperglycemic, hypolipidemic, hepatoprotective and antioxidative effects of dietary clove (Szyzgium aromaticum) bud powder in a high-fat diet/streptozotocin-induced diabetes rat model. J Sci Food Agric 94: 2726-2737.
2. Chen WC, Liou SS, Tzeng TF, Lee SL, Liu IM,. 2012. Wound repair and anti-inflammatory potential of Lonicera japonica in excision wound-induced rats. BMC Complement Altern Med 12: 226. [Available at: http://www.biomedcentral.com/bmccomplementalternmed/about ].
3. Cnop M, Welsh N, Jonas JC, Jorns A, Lenzen S, Eizirik DL,. 2005. Mechanisms of pancreatic beta-cell death in type 1 and type 2 diabetes: many differences, few similarities. Diabetes 54: S97-107.
4. Draznin B,. 2006. Molecular mechanisms of insulin resistance: serine phosphorylation of insulin receptor substrate-1 and increased expression of p85alpha: the two sides of a coin. Diabetes 55: 2392-2397.
5. Ergul A, Li W, Elgebaly MM, Bruno A, Fagan SC,. 2009. Hyperglycemia, diabetes and stroke: focus on the cerebrovasculature. Vascul Pharmacol 51: 44-49.
6. Gomez-Peralta F, Abreu PC,. 2014. Do we need new treatments for type 2 diabetes? Endocrinol Nutr 61: 323-328.
7. Hevener AL, He W, Barak Y, et al., 2003. Muscle-specific pparg deletion causes insulin resistance. Nat Med 9: 1491-1497.
8. Hu FB,. 2011. Globalization of diabetes: the role of diet, lifestyle, and genes. Diabetes Care 34: 1249-1257.
9. International Diabetes Federation (IDF). 2013. IDF diabetes atlas (6th edn). Available on-line at http// www.idf.org/diabetesatlas (accessed Jan 30, 2014).
10. Kahn SE,. 2001. Clinical review 135: the importance of beta-cell failure in the development and progression of type 2 diabetes. J Clin Endocrinol Metab 86: 4047-4058.
11. Kim SH, Sung MJ, Park JH, Yang HJ, Hwang JT,. 2013. Boehmeria nivea stimulates glucose uptake by activating peroxisome proliferator-activated receptor gamma in C2C12 cells and improves glucose intolerance in mice fed a high-fat diet. Evid Based Complement Alternat Med 2013: 867-893.
12. Kwak WJ, Han CK, Chang HW, Kim HP, Kang SS, Son KH,. 2003. Loniceroside C, an antiinflammatory saponin from Lonicera japonica. Chem Pharm Bull 51: 333-335.
13. Kwon SH, Hong SI, Jung YH, et al., 2012. Lonicera japonica Thunb. protects 6-hydroxydopamine-induced neurotoxicity by inhibiting activation of MAPKs, PI3K/Akt, and NF-kappaB in SH-SY5Y cells. Food Chem Toxicol 50: 797-807.
14. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC,. 1985. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412-419.
15. Moller DE,. 2001. New drug targets for type 2 diabetes and the metabolic syndrome. Nature 414: 821-827.
16. Morimoto A, Tatsumi Y, Soyano F, et al,. 2014. Increase in homeostasis model assessment of insulin resistance (HOMA-IR) had a strong impact on the development of type 2 diabetes in Japanese individuals with impaired insulin secretion: the saku study. Plos One 9: e105827.
17. Mukherjee PK, Maiti K, Mukherjee K, Houghton PJ,. 2006. Leads from Indian medicinal plants with hypoglycemic potentials. J Ethnopharmacol 106: 1-28.
18. Muoio DM, Newgard CB,. 2008. Mechanisms of disease: molecular and metabolic mechanisms of insulin resistance and beta-cell failure in type 2 diabetes. Nat Rev Mol Cell Biol 9: 193-205.
19. Mythili MD, Vyas R, Akila G, Gunasekaran S,. 2004. Effect of streptozotocin on the ultrastructure of rat pancreatic islets. Microsc Res Tech 63: 274-281.
20. Park HS, Park KI, Lee DH, et al., 2012. Polyphenolic extract isolated from Korean Lonicera japonica Thunb. induce G2/M cell cycle arrest and apoptosis in HepG2 cells: involvements of PI3K/Akt and MAPKs. Food Chem Toxicol 50: 2407-2416.
21. Reed MJ, Meszaros K, Entes LJ, et al., 2000. A new rat model of type 2 diabetes: the fat-fed, streptozotocin-treated rat. Metabolism 49: 1390-1394.
22. Saad MJ, Araki E, Miralpeix M, Rothenberg PL, White MF, Kahn CR,. 1992. Regulation of insulin receptor substrate-1 in liver and muscle of animal models of insulin resistance. J Clin Invest 90: 1839-1849.
23. Saltiel AR, Pessin JE,. 2002. Insulin signaling pathways in time and space. Trends Cell Biol 12: 65-71.
24. Samuel VT, Shulman GI,. 2012. Mechanisms for insulin resistance: common threads and missing links. Cell 148: 852-871.
25. Schmidt BM, Ribnicky DM, Lipsky PE, Raskin I,. 2007. Revisiting the ancient concept of botanical therapeutics. Nat Chem Biol 3: 360-366.
26. Storlien LH, James DE, Burleigh KM, Chisholm DJ, Kraegen EW,. 1986. Fat feeding causes widespread in vivo insulin resistance, decreased energy expenditure, and obesity in rats. Am J Physiol 251: E576-583.
27. Stumvoll M, Goldstein BJ, van Haeften TW,. 2005. Type 2 diabetes: principles of pathogenesis and therapy. Lancet 365: 1333-1346.
28. Tao X, Wang X, Jia W,. 2007. Using Chinese natural products for diabetes mellitus drug discovery and development. Expert Opin Drug Discov 2: 977-986.
29. Xiong J, Li S, Wang W, Hong Y, Tang K, Luo Q,. 2013. Screening and identification of the antibacterial bioactive compounds from Lonicera japonica Thunb. leaves. Food Chem 138: 327-333.
30. Xue J, Ding W, Liu Y,. 2010. Anti-diabetic effects of emodin involved in the activation of PPARgamma on high-fat diet-fed and low dose of streptozotocin-induced diabetic mice. Fitoterapia 81: 173-177.
31. Zhang M, Lv XY, Li J, Xu ZG, Chen L,. 2008. The characterization of high-fat diet and multiple low-dose streptozotocin induced type 2 diabetes rat model. Exp Diabetes Res 2008: 704045.